BELLINI, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 1.101
EU - Europa 958
AS - Asia 194
SA - Sud America 3
OC - Oceania 2
Totale 2.258
Nazione #
US - Stati Uniti d'America 1.099
IE - Irlanda 303
CN - Cina 159
UA - Ucraina 150
GB - Regno Unito 134
IT - Italia 109
DE - Germania 107
SE - Svezia 53
FI - Finlandia 37
TR - Turchia 31
FR - Francia 25
GR - Grecia 19
BE - Belgio 12
NL - Olanda 4
SI - Slovenia 3
CA - Canada 2
CL - Cile 2
IN - India 2
AR - Argentina 1
AU - Australia 1
JP - Giappone 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RU - Federazione Russa 1
SG - Singapore 1
Totale 2.258
Città #
Dublin 302
Chandler 265
Jacksonville 222
Beijing 50
Ann Arbor 48
Woodbridge 48
Boardman 40
Princeton 38
Medford 35
Bremen 34
Caserta 34
San Mateo 30
Ashburn 25
Wilmington 24
Dearborn 21
Nanjing 20
New York 18
Kunming 14
Brussels 12
Auburn Hills 10
Jinan 10
Mugnano di Napoli 10
Roxbury 10
Düsseldorf 9
Hefei 9
Cambridge 8
Des Moines 7
Los Angeles 7
Napoli 6
Redwood City 6
Guangzhou 5
Hebei 5
Houston 5
Nanchang 5
Shanghai 5
Hangzhou 4
Mountain View 4
Naples 4
Ningbo 4
Venice 4
Zhengzhou 4
Centrale 3
Falls Church 3
Ljubljana 3
Shenyang 3
Amsterdam 2
Bologna 2
Brusciano 2
Changchun 2
Chongqing 2
Elice 2
Fairfield 2
Hampstead 2
Lanzhou 2
Lissone 2
Milan 2
Norwalk 2
Pistoia 2
Rome 2
Santiago 2
Voghera 2
Xian 2
Atlanta 1
Bloomington 1
Budenheim 1
Catanzaro 1
Changsha 1
Christchurch 1
Dallas 1
Elora 1
Fiano Romano 1
Florence 1
Fremont 1
Fuzhou 1
Groningen 1
Harbin 1
Huzhou 1
Jiaxing 1
Kansas City 1
London 1
Malden 1
Melrose 1
Merlo 1
Nanning 1
Nuremberg 1
Ottawa 1
Parma 1
Pomigliano d'Arco 1
Sacramento 1
Salerno 1
Sant'anastasia 1
Secaucus 1
Sunshine Coast 1
Tappahannock 1
Teano 1
Tianjin 1
Tokyo 1
Washington 1
Wenzhou 1
Yinchuan 1
Totale 1.505
Nome #
Endocannabinoid Research Group (ERG), Italy. The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy. 83
HNF-1β mutation affects PKD2 and SOCS3 expression causing renal cysts and diabetes in MODY5 kindred. 76
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 75
Changes in cannabinoid receptor subtype 1 activity and interaction with metabotropic glutamate subtype 5 receptors in the periaqueductal gray-rostral ventromedial medulla pathway in a rodent neuropathic pain model. 73
The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats. 72
Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease 72
EP1 receptor within the ventrolateral periaqueductal grey controls thermonociception and rostral ventromedial medulla cell activity in healthy and neuropathic rat 72
null 71
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties. 69
The 17-β-oestradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression. 68
TNF-α effect on human delivery onset by CB1/TRPV1 crosstalk: new insights into endocannabinoid molecular signaling in preterm vs. term labor. Analysis of the EC/EV pathway and predictive biomarkers for early diagnosis of preterm delivery 67
The genetic ablation or pharmacological inhibition of TRPV1 signalling is beneficial for the restoration of quiescent osteoclast activity in ovariectomized mice. 64
The A1 adenosine receptor as a new player in microglia physiology 64
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura. 63
The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention. 63
Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S4 region of KCNQ2 causing benign familial neonatal convulsions 61
The 17-estradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression 61
Benign Familial Neonatal Seizures 61
Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial/microglial phenotypical changes in mice 60
Iron overload causes osteoporosis in Thalassemia Major patients through interaction with TRPV1 channels. 59
Effects of a metabotropic glutamate receptor subtype 7 negative allosteric modulator in the periaqueductal grey on pain responses and rostral ventromedial medulla cell activity in rat 58
A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes 57
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 57
A novel hyperekplexia-causing mutation in the pre-transmembrane segment 1 of the human glycine receptor alpha1 subunit reduces membrane expression and impairs gating by agonists 56
Association of the cannabinoid receptor 2 (CB2) Gln63Arg polymorphism with indices of liver damage in obese children: An alternative way to highlight the CB2 hepatoprotective properties. 56
A mutation (V260M) in the middle of the M2 pore-lining domain of the glycine receptor causes hereditary hyperekplexia 55
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 55
Decreased subunit stability as a novel mechanism for potassium current impairment by a KCNQ2 C terminus mutation causing benign familial neonatal convulsions 54
Mutational scanning of potassium, sodium and chloride ion channels in malignant migrating partial seizures in infancy 52
A novel mutation (R218Q) at the boundary between the N-terminal and the first transmembrane domain of the glycine receptor in a case of sporadic hyperekplexia 52
Hyperekplexia caused by dominant-negative suppression of glyra1 function 49
Neutralization of a unique, negatively-charged residue in the voltage sensor of K V 7.2 subunits in a sporadic case of benign familial neonatal seizures 47
La presenza della variante Q63 del recettore dei cannabinoidi (CB2) si associa ad un più severa epatonecrosi nei pazienti con epatite cronica C. 46
Benign Familial Neonatal Seizures . In: editors. Seattle (WA): Apr 27 41
Benign familial neonatal convulsions (BFNC) resulting from mutation of the KCNQ2 voltage sensor 40
Familial occurrence of early-onset childhood absence epilepsy 39
No evidence for association between dyslexia and DYX1C1 functional variants in a group of children and adolescents from Southern Italy. 37
EXCLUSION DE LINKAGE A 8Q24 DANS UNE FAMILLE AVEC ABSENCE DE L'ENFANCE A DEBUT PRECOCE ET TOLERANCE REDUITE AU VPA 31
The endovanilloid/endocannabinoid system in human osteoclasts: Possible involvement in bone formation and resorption 31
The CB2-63 RR variant is an independent predictor of severe liver necroinflammation in chronic hepatitis B 27
null 26
Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C 24
Totale 2.344
Categoria #
all - tutte 7.346
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.346


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201913 0 0 0 0 0 0 0 0 0 7 4 2
2019/2020403 43 39 4 7 52 30 104 51 32 24 10 7
2020/2021341 37 0 50 14 58 5 45 34 2 51 30 15
2021/2022286 33 3 0 6 91 3 8 6 6 51 20 59
2022/2023768 47 31 15 100 93 70 0 46 331 9 9 17
2023/2024190 29 7 5 24 67 25 5 22 0 6 0 0
Totale 2.344